Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation
To examine the gap between evidence-based indications for PSMA PET/CT and real-world access in prostate cancer, with a focus on European implementation and country-specific experience from Spain and France. A focused narrative appraisal of published evidence, clinical guidelines, regulatory and reimbursement informatio...